XOMA Royalty (XOMA) Other Non-Current Liabilities (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Other Non-Current Liabilities came in at $3.7 million in Q1 2026, up 12.0% year-on-year from $3.3 million in Q1 2025, and up 2.89% quarter-over-quarter from $3.6 million in Q4 2025.

XOMA Royalty (XOMA) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Other Non-Current Liabilities across 16 years of filings, most recently posting $3.7 million for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $3.7 million, up 12.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 12.0% YoY), and the FY2025 annual result was $3.6 million, up 12.01% from the prior year.
  • Other Non-Current Liabilities came in at $3.7 million for Q1 2026 at XOMA Royalty, up from $3.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.1 million in Q1 2023 to a low of $2.9 million in Q2 2024.
  • The 4-year median for Other Non-Current Liabilities is $3.4 million (2025), against an average of $3.4 million.
  • Peak annual rise in Other Non-Current Liabilities reached 16.43% in 2025, while the deepest fall reached 12.0% in 2025.
  • XOMA Royalty's Other Non-Current Liabilities stood at $4.1 million in 2023, then retreated by 22.22% to $3.2 million in 2024, then advanced by 12.01% to $3.6 million in 2025, then rose by 2.89% to $3.7 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $3.7 million (Q1 2026), $3.6 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 XOMA Royalty 5.52 Mn -60.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.70 Mn
Dec 31, 2025 3.60 Mn
Sep 30, 2025 3.50 Mn
Jun 30, 2025 3.40 Mn
Mar 31, 2025 3.31 Mn
Dec 31, 2024 3.21 Mn
Sep 30, 2024 3.13 Mn
Jun 30, 2024 2.92 Mn
Mar 31, 2023 4.13 Mn
Sep 30, 2021 20,000.00
Jun 30, 2021 20,000.00
Mar 31, 2021 102,000.00
Dec 31, 2020 50,000.00
Sep 30, 2020 134,000.00
Jun 30, 2020 35,000.00
Mar 31, 2020 200,000.00
Dec 31, 2019 43,000.00
Sep 30, 2019 457,000.00
Jun 30, 2019 294,000.00
Mar 31, 2019 100,000.00